Scripps was the first health care system in San Diego to offer HeartFlow FFR-CT Analysis (HeartFlow) — a non-invasive, 3-D technology to accurately test for coronary artery disease (CAD).
When you have symptoms of coronary artery disease, your doctor may order a CT scan to look for blockages in your arteries. Sometimes, a CT scan provides enough information. Other times, more information is needed.
The HeartFlow Analysis is an advanced test that shows how each blockage impacts blood flow to your heart. It provides helpful information that your doctor can use to determine the next step in your treatment plan.
Coronary artery disease, also called coronary heart disease, is the leading cause of death for both men and women in the United States. CAD develops when the arteries leading to the heart narrow, often because of the buildup of plaque in the vessel walls. The coronary narrowing can cut off vital blood flow to the heart, causing chest pain, heart attacks and death.
Physicians at Scripps now have access to the non-invasive HeartFlow FFR-CT Analysis, a technology that will help them identify the appropriate treatment plan for patients with coronary artery disease. This diagnostic tool is the first non-invasive technology to offer physicians insight into both the extent of a patient’s arterial blockage and the impact the blockage has on blood flow.
The HeartFlow technology creates a personalized, digital 3D model of each patient’s arteries using the images derived from a standard, non-invasive coronary CT angiogram. Powerful computer algorithms then solve millions of complex equations to assess the impact of blockages on blood flow. This information aids physicians in determining the appropriate course of action for each patient.
Using a color-coded, 3-D model technology, HeartFlow provides a more accurate and detailed analysis of your arteries to determine if you have CAD. Some benefits include:
- A more detailed view on the functional significance of your coronary artery blockage than a standard CT scan
- Non-invasive — no incisions or injections in your body are required to use the technology after the CT scan
- Reduces the need for follow-up testing and evaluation to detect CAD
- Helps doctors better determine the appropriate treatment of care for you
- No extra dye, extra radiation or extra patient time is required after the CT scan
- Can be performed from previously recorded CT scans; Scripps can accept CT scans from anywhere in the world